Gain Therapeutics, Inc. (GANX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $22.82M | +88.2% |
| 2024 | $12.12M | -34.9% |
| 2023 | $18.61M | -22.8% |
| 2022 | $24.10M | -38.2% |
| 2021 | $38.99M | +305.9% |
| 2020 | $9.60M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $22.82M | +88.2% |
| 2024 | $12.12M | -34.9% |
| 2023 | $18.61M | -22.8% |
| 2022 | $24.10M | -38.2% |
| 2021 | $38.99M | +305.9% |
| 2020 | $9.60M | — |